APO RESEARCH · REPORT
Levothyroxine
Levothyroxine is used to treat low thyroid activity and to treat or suppress different types of goiters.
Product & engineering
Understand the product.
Levothyroxine is used to treat low thyroid activity and to treat or suppress different types of goiters.
Levothyroxine is a replacement for a hormone normally produced by your thyroid gland to regulate the body's energy and metabolism. Levothyroxine is given when the thyroid does not produce enough of this hormone on its own.
Levothyroxine treats hypothyroidism (low thyroid hormone). It is also used to treat or prevent goiter (enlarged thyroid gland), which can be caused by hormone imbalances, radiation treatment, surgery, or cancer.
Selected research
Industry Research
Levothyroxine Industry Research Report 2026
Market perspective
Levothyroxine is used to treat low thyroid activity and to treat or suppress different types of goiters.
Levothyroxine is a replacement for a hormone normally produced by your thyroid gland to regulate the body's energy and metabolism. Levothyroxine is given when the thyroid does not produce enough of this hormone on its own.
Levothyroxine treats hypothyroidism (low thyroid hormone). It is also used to treat or prevent goiter (enlarged thyroid gland), which can be caused by hormone imbalances, radiation treatment, surgery, or cancer.
Read the full market overview
In United States, the key Levothyroxine manufacturers are Abbott Ltd, Alara Pharm (Sandoz), Forest (Actavis), Merck Serono, Piramal Healthcare, Mylan, KING PHARMS R AND D, Jerome Stevens etc. Top 3 companies occupied about 69% market share.
Report Scope
This report quantifies the global Levothyroxine market in terms of revenue (US$ million) and, where applicable, sales volume (K t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Levothyroxine Market by Company
Abbott Ltd
Alara Pharm (Sandoz)
Forest (Actavis)
Merck Serono
Piramal Healthcare
Mylan
KING PHARMS R AND D
Jerome Stevens
Levothyroxine Segment by Type
Slice in Solid
In Bottles for Injection
Levothyroxine Segment by Application
Hospitals
Chemist's Shops
Others
Levothyroxine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Levothyroxine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Levothyroxine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Levothyroxine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Levothyroxine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Levothyroxine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Levothyroxine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Slice in Solid
- In Bottles for Injection
Applications
- Hospitals
- Chemist's Shops
- Others
Companies covered
- Abbott Ltd
- Alara Pharm (Sandoz)
- Forest (Actavis)
- Merck Serono
- Piramal Healthcare
- Mylan
- KING PHARMS R AND D
- Jerome Stevens
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Levothyroxine Market Size (2021-2032)
- 2.2.2 Global Levothyroxine Sales (2021-2032)
- 2.2.3 Global Levothyroxine Market Average Price (2021-2032)
- 2.3 Levothyroxine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Slice in Solid
- 2.3.3 In Bottles for Injection
- 2.4 Levothyroxine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Chemist's Shops
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Levothyroxine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Levothyroxine Sales (K t) of Manufacturers (2021-2026)
- 3.3 Global Levothyroxine Revenue of Manufacturers (2021-2026)
- 3.4 Global Levothyroxine Average Price by Manufacturers (2021-2026)
- 3.5 Global Levothyroxine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Levothyroxine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Levothyroxine, Product Type & Application
- 3.8 Global Manufacturers of Levothyroxine, Established Date
- 3.9 Global Levothyroxine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott Ltd
- 4.1.1 Abbott Ltd Company Information
- 4.1.2 Abbott Ltd Business Overview
- 4.1.3 Abbott Ltd Levothyroxine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Ltd Levothyroxine Product Portfolio
- 4.1.5 Abbott Ltd Recent Developments
- 4.2 Alara Pharm (Sandoz)
- 4.2.1 Alara Pharm (Sandoz) Company Information
- 4.2.2 Alara Pharm (Sandoz) Business Overview
- 4.2.3 Alara Pharm (Sandoz) Levothyroxine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Alara Pharm (Sandoz) Levothyroxine Product Portfolio
- 4.2.5 Alara Pharm (Sandoz) Recent Developments
- 4.3 Forest (Actavis)
- 4.3.1 Forest (Actavis) Company Information
- 4.3.2 Forest (Actavis) Business Overview
- 4.3.3 Forest (Actavis) Levothyroxine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Forest (Actavis) Levothyroxine Product Portfolio
- 4.3.5 Forest (Actavis) Recent Developments
- 4.4 Merck Serono
- 4.4.1 Merck Serono Company Information
- 4.4.2 Merck Serono Business Overview
- 4.4.3 Merck Serono Levothyroxine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck Serono Levothyroxine Product Portfolio
- 4.4.5 Merck Serono Recent Developments
- 4.5 Piramal Healthcare
- 4.5.1 Piramal Healthcare Company Information
- 4.5.2 Piramal Healthcare Business Overview
- 4.5.3 Piramal Healthcare Levothyroxine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Piramal Healthcare Levothyroxine Product Portfolio
- 4.5.5 Piramal Healthcare Recent Developments
- 4.6 Mylan
- 4.6.1 Mylan Company Information
- 4.6.2 Mylan Business Overview
- 4.6.3 Mylan Levothyroxine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mylan Levothyroxine Product Portfolio
- 4.6.5 Mylan Recent Developments
- 4.7 KING PHARMS R AND D
- 4.7.1 KING PHARMS R AND D Company Information
- 4.7.2 KING PHARMS R AND D Business Overview
- 4.7.3 KING PHARMS R AND D Levothyroxine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 KING PHARMS R AND D Levothyroxine Product Portfolio
- 4.7.5 KING PHARMS R AND D Recent Developments
- 4.8 Jerome Stevens
- 4.8.1 Jerome Stevens Company Information
- 4.8.2 Jerome Stevens Business Overview
- 4.8.3 Jerome Stevens Levothyroxine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jerome Stevens Levothyroxine Product Portfolio
- 4.8.5 Jerome Stevens Recent Developments
5 Global Levothyroxine Market Scenario by Region
- 5.1 Global Levothyroxine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Levothyroxine Sales by Region: 2021-2032
- 5.2.1 Global Levothyroxine Sales by Region: 2021-2026
- 5.2.2 Global Levothyroxine Sales by Region: 2027-2032
- 5.3 Global Levothyroxine Revenue by Region: 2021-2032
- 5.3.1 Global Levothyroxine Revenue by Region: 2021-2026
- 5.3.2 Global Levothyroxine Revenue by Region: 2027-2032
- 5.4 North America Levothyroxine Market Facts & Figures by Country
- 5.4.1 North America Levothyroxine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Levothyroxine Sales by Country (2021-2032)
- 5.4.3 North America Levothyroxine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Levothyroxine Market Facts & Figures by Country
- 5.5.1 Europe Levothyroxine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Levothyroxine Sales by Country (2021-2032)
- 5.5.3 Europe Levothyroxine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Levothyroxine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Levothyroxine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Levothyroxine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Levothyroxine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Levothyroxine Market Facts & Figures by Country
- 5.7.1 South America Levothyroxine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Levothyroxine Sales by Country (2021-2032)
- 5.7.3 South America Levothyroxine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Levothyroxine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Levothyroxine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Levothyroxine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Levothyroxine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Levothyroxine Sales by Type (2021-2032)
- 6.1.1 Global Levothyroxine Sales by Type (2021-2032) & (K t)
- 6.1.2 Global Levothyroxine Sales Market Share by Type (2021-2032)
- 6.2 Global Levothyroxine Revenue by Type (2021-2032)
- 6.2.1 Global Levothyroxine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Levothyroxine Revenue Market Share by Type (2021-2032)
- 6.3 Global Levothyroxine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Levothyroxine Sales by Application (2021-2032)
- 7.1.1 Global Levothyroxine Sales by Application (2021-2032) & (K t)
- 7.1.2 Global Levothyroxine Sales Market Share by Application (2021-2032)
- 7.2 Global Levothyroxine Revenue by Application (2021-2032)
- 7.2.1 Global Levothyroxine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Levothyroxine Revenue Market Share by Application (2021-2032)
- 7.3 Global Levothyroxine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Levothyroxine Value Chain Analysis
- 8.1.1 Levothyroxine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Levothyroxine Production Mode & Process
- 8.2 Levothyroxine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Levothyroxine Distributors
- 8.2.3 Levothyroxine Customers
9 Global Levothyroxine Analyzing Market Dynamics
- 9.1 Levothyroxine Industry Trends
- 9.2 Levothyroxine Industry Drivers
- 9.3 Levothyroxine Industry Opportunities and Challenges
- 9.4 Levothyroxine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst